{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:29:20Z","timestamp":1791437360185,"version":"4.3.3"},"reference-count":308,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2023,8,11]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Neurological involvement in Beh\u00e7et\u2019s syndrome arises predominately through an inflammatory meningoencephalitis characterised by perivenular inflammation due to activation of Th-17 immunological pathways. The brainstem is involved in 50% of cases, the diencephalon and other areas of the brain in 30%, and the spinal cord in 10%. Movement disorders and epilepsy may occur. Psychiatric syndromes may arise with brain and brainstem involvement, and cognitive disorders relate to the brain disease, to circulating inflammatory factors, and to fatigue and despondency. Eighty per cent of cases begin with a relapsing disease course, of whom 70% have only one attack, and 30% have a progressive disease course either from onset or following an initially relapsing course. Venous thrombosis leading to intracranial hypertension and cerebral venous infarction is less common and caused by inflammation in affected veins and a circulating prothrombotic state. Arterial involvement is rare and relates to an arteritis affecting large-sized and medium-sized vessels within the brain leading to infarction, subarachnoid and parenchymal haemorrhage, aneurysm formation and arterial dissection. There is a newly recognised disorder of cerebral cortical hypoperfusion. Cranial neuropathy, peripheral neuropathy and myositis are rare. There has been significant progress in understanding the pathophysiology and treatment of the systemic disease, leading to improved outcomes, but there has been no randomised trial of treatment in the neurological disorder.<\/jats:p>","DOI":"10.1136\/pn-2023-003875","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T06:55:12Z","timestamp":1695970512000},"page":"386-400","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Neurological involvement by Beh\u00e7et\u2019s syndrome: clinical features, diagnosis, treatment and outcome"],"prefix":"10.1136","volume":"23","author":[{"given":"Desmond Patrick","family":"Kidd","sequence":"first","affiliation":[{"name":"The Royal London Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"2025090411013412000_23.5.386.1","first-page":"1078","article-title":"International study group for Beh\u00e7et\u2019s disease. criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"2025090411013412000_23.5.386.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.2.115"},{"key":"2025090411013412000_23.5.386.3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12107"},{"key":"2025090411013412000_23.5.386.4","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2018.3","article-title":"Behcet syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2025090411013412000_23.5.386.5","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0436"},{"key":"2025090411013412000_23.5.386.6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Beh\u00e7et\u2019s disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"2025090411013412000_23.5.386.7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et's disease: new insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2025090411013412000_23.5.386.8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Beh\u00e7et\u2019s disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front Immunol"},{"key":"2025090411013412000_23.5.386.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.147"},{"key":"2025090411013412000_23.5.386.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.24642"},{"key":"2025090411013412000_23.5.386.11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","article-title":"Pathogenesis of Beh\u00e7et\u2019s disease: Autoinflammatory features and beyond","volume":"37","author":"G\u00fcl","year":"2015","journal-title":"Semin Immunopathol"},{"key":"2025090411013412000_23.5.386.12","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.1999.540301.x"},{"key":"2025090411013412000_23.5.386.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.06.002"},{"key":"2025090411013412000_23.5.386.14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","article-title":"Beh\u00e7et\u2019s syndrome patients exhibit specific Microbiome signature","volume":"14","author":"Consolandi","year":"2015","journal-title":"Autoimmunity Reviews"},{"key":"2025090411013412000_23.5.386.15","doi-asserted-by":"publisher","DOI":"10.3109\/08830189709116842"},{"issue":"4 Suppl 45","key":"2025090411013412000_23.5.386.16","first-page":"S27","article-title":"The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Beh\u00e7et\u2019s disease","volume":"25","author":"Mumcu","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.17","doi-asserted-by":"publisher","DOI":"10.1136\/gut.18.6.491"},{"key":"2025090411013412000_23.5.386.18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3349\/ymj.2016.57.1.22","article-title":"Intestinal Behcet\u2019s disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"2025090411013412000_23.5.386.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5885-9"},{"key":"2025090411013412000_23.5.386.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu233"},{"key":"2025090411013412000_23.5.386.21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000494","article-title":"Behcet disease with vascular involvement: effects of different therapeutic regimes on the incidence of new relapses","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025090411013412000_23.5.386.22","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2011.026","article-title":"Beh\u00e7et\u2019s syndrome and thrombosis","volume":"3","author":"Seyahi","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2025090411013412000_23.5.386.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(97)90284-1"},{"key":"2025090411013412000_23.5.386.24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182428126"},{"key":"2025090411013412000_23.5.386.25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00859.x"},{"key":"2025090411013412000_23.5.386.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70015-8"},{"key":"2025090411013412000_23.5.386.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1951.tb09687.x"},{"key":"2025090411013412000_23.5.386.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneurpsyc.1956.02330190009001","article-title":"The neurological complications of Beh\u00e7et\u2019s syndrome","volume":"75","author":"Pallis","year":"1956","journal-title":"Arch NeurPsych"},{"key":"2025090411013412000_23.5.386.29","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/80.1.59"},{"key":"2025090411013412000_23.5.386.30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(57)92589-8","article-title":"Involvement of the nervous system in Beh\u00e7et\u2019s syndrome: report of three cases and isolation of virus","volume":"273","author":"EVANS","year":"1957","journal-title":"Lancet"},{"key":"2025090411013412000_23.5.386.31","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(63)90078-0"},{"key":"2025090411013412000_23.5.386.32","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90166-2"},{"key":"2025090411013412000_23.5.386.33","first-page":"493","article-title":"Manifestations Neurologiques de la Maladie Du Behcet","volume":"138","author":"Rougemont","year":"1982","journal-title":"Vingt-Quatre Observations Rev Neurol (Paris)"},{"key":"2025090411013412000_23.5.386.34","unstructured":"Hentati FFM , Gharbi N , Hamida M . Clinical and biological aspects of neuro-Beh\u00e7et\u2019s disease in Tunisia. In: Wechsler B , Godeau P , eds. Beh\u00e7et\u2019s disease. Amsterdam: Elsevier, 1993: 415\u20138."},{"key":"2025090411013412000_23.5.386.35","unstructured":"Bohlega S , Al Kawi MZ , Omer S . Neuro-Beh\u00e7et\u2019s: clinical syndromes and prognosis. In: Wechsler B , Godeau P , eds. Beh\u00e7et\u2019s disease. Amsterdam: Elsevier, 1993: 429\u201333."},{"key":"2025090411013412000_23.5.386.36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.3.382"},{"key":"2025090411013412000_23.5.386.37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.11.2183"},{"key":"2025090411013412000_23.5.386.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.11.2171"},{"key":"2025090411013412000_23.5.386.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00165-3"},{"key":"2025090411013412000_23.5.386.40","doi-asserted-by":"publisher","DOI":"10.1007\/s004150170242"},{"key":"2025090411013412000_23.5.386.41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1468-1331.2001.00177.x","article-title":"The clinical involvement Patters of neuro-Beh\u00e7et\u2019s disease","volume":"8","author":"Y\u00fccesan","year":"2001","journal-title":"Eur J Neurol"},{"key":"2025090411013412000_23.5.386.42","doi-asserted-by":"publisher","DOI":"10.1007\/s004150200031"},{"key":"2025090411013412000_23.5.386.43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/0-306-48382-3_75","article-title":"Neuro-Beh\u00e7et\u2019s disease (isolated cerebral thrombophlebitis excluded). clinical pattern, Prognostic factors, treatment and long term follow up","volume":"528","author":"Sba\u00ef","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"2025090411013412000_23.5.386.44","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.5.608"},{"key":"2025090411013412000_23.5.386.45","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0035-3787(06)75121-9","article-title":"Neurological involvement in Beh\u00e7et\u2019s disease. 154 cases from a cohort of 925 patients and review of the literature","volume":"162","author":"Benamour","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"2025090411013412000_23.5.386.46","first-page":"1542","article-title":"Neurological manifestations of Beh\u00e7et\u2019s disease","volume":"27","author":"Borhani-Haghighi","year":"2006","journal-title":"Saudi Med J"},{"key":"2025090411013412000_23.5.386.47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00296-006-0149-9","article-title":"Neurological involvement in North Italian patients with Beh\u00e7Et disease","volume":"26","author":"Lo Monaco","year":"2006","journal-title":"Rheumatol Int"},{"key":"2025090411013412000_23.5.386.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01613.x"},{"key":"2025090411013412000_23.5.386.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5454-2"},{"key":"2025090411013412000_23.5.386.50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-011-0533-5","article-title":"Clinical characteristics of neuro-Beh\u00e7et\u2019s disease in Japan: a multicenter retrospective analysis","volume":"22","author":"Hirohata","year":"2012","journal-title":"Mod Rheumatol"},{"key":"2025090411013412000_23.5.386.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.06.009"},{"key":"2025090411013412000_23.5.386.52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1756-185X.12265","article-title":"Neuro-Beh\u00e7et\u2019s disease in South Korea: clinical characteristics and treatment response","volume":"17","author":"Yoon","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"2025090411013412000_23.5.386.53","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/art.38351","article-title":"Long-Tern outcome of neuro-Beh\u00e7et\u2019s disease","volume":"66","author":"Noel","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025090411013412000_23.5.386.54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5152\/eurjrheum.2018.18033","article-title":"Clinical characteristics and prognosis of neuro-Beh\u00e7et\u2019s disease","volume":"5","author":"Sorgun","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"2025090411013412000_23.5.386.55","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7371458","article-title":"The clinical features and risk factors of Parenchymal neuro-Beh\u00e7et\u2019s disease","volume":"2019","author":"Yan","year":"2019","journal-title":"J Immunol Res"},{"key":"2025090411013412000_23.5.386.56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3988\/jcn.2019.15.4.429","article-title":"Clinical and radiographic characteristics of neuro-Beh\u00e7et\u2019s disease in South Korea","volume":"15","author":"Kim","year":"2019","journal-title":"J Clin Neurol"},{"key":"2025090411013412000_23.5.386.57","doi-asserted-by":"crossref","first-page":"101512","DOI":"10.1016\/j.msard.2019.101512","article-title":"Clinical features and disease course of neurological involvement in Beh\u00e7et\u2019s disease: HUVAC experience","volume":"38","author":"Bolek","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"2025090411013412000_23.5.386.58","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker449"},{"key":"2025090411013412000_23.5.386.59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clineuro.2017.08.004","article-title":"Cerebral pseudo-Tumoral neuro-Behcet: histological demonstration of an inflammatory and vascular disease","volume":"161","author":"Cohen-Aubart","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"2025090411013412000_23.5.386.60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21767\/2171-6625.1000235","article-title":"Tumefactive neuro\u2013Beh\u00e7et\u2019s disease: a case report and review of the literature","volume":"08","author":"Kuzu","year":"2017","journal-title":"J Neurol Neurosci"},{"key":"2025090411013412000_23.5.386.61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1445-5994.2001.00134.x","article-title":"Beh\u00e7et\u2019s disease with cerebral vasculitis","volume":"31","author":"Scardamaglia","year":"2001","journal-title":"Intern Med J"},{"key":"2025090411013412000_23.5.386.62","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2176\/nmc.42.406","article-title":"Neuro-Beh\u00e7et\u2019s disease manifesting as a Neoplasm-like lesion--case report","volume":"42","author":"Imoto","year":"2002","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2025090411013412000_23.5.386.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.07.029"},{"key":"2025090411013412000_23.5.386.64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jocn.2016.03.020","article-title":"Neuro-Beh\u00e7et\u2019s disease presenting with tumour-like lesions and responding to Rituximab","volume":"32","author":"Jade","year":"2016","journal-title":"J Clin Neurosci"},{"key":"2025090411013412000_23.5.386.65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ensci.2017.06.001","article-title":"Brain biopsy to aid diagnosis of neuro-Beh\u00e7et\u2019s disease: case report and literature review","volume":"8","author":"Yamada","year":"2017","journal-title":"eNeurologicalSci"},{"key":"2025090411013412000_23.5.386.66","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1308\/rcsann.2019.0134","article-title":"Brain Pseudotumour secondary to Beh\u00e7et\u2019s disease","volume":"101","author":"Mousa","year":"2019","journal-title":"Ann R Coll Surg Engl"},{"key":"2025090411013412000_23.5.386.67","first-page":"300","article-title":"Fascicular Oculomotor nerve palsy in neuro-Beh\u00e7et\u2019s disease","volume":"11","author":"Saribas","year":"1991","journal-title":"J Clin Neuroophthalmol"},{"key":"2025090411013412000_23.5.386.68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0404.2003.00019.x","article-title":"A neuro-Beh\u00e7et\u2019s lesion in Oculomotor nerve nucleus","volume":"108","author":"Aydin","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"2025090411013412000_23.5.386.69","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311334"},{"key":"2025090411013412000_23.5.386.70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3349\/ymj.1999.40.3.294","article-title":"Neuro-Beh\u00e7et\u2019s disease presenting with isolated unilateral lateral rectus muscle palsy","volume":"40","author":"Lew","year":"1999","journal-title":"Yonsei Med J"},{"key":"2025090411013412000_23.5.386.71","first-page":"848","article-title":"Isolated Hypoglossal nerve palsy in Beh\u00e7et\u2019s disease","volume":"26","author":"Ko","year":"1997","journal-title":"Ann Acad Med Singap"},{"key":"2025090411013412000_23.5.386.72","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10067-003-0708-3","article-title":"Sudden hoarseness due to unilateral cord vocal paralysis in a patient with Beh\u00e7et\u2019s disease","volume":"22","author":"Pirildar","year":"2003","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1085-9489.2004.009203.x","article-title":"Neuro-Beh\u00e7et\u2019s syndrome may present with peripheral Paresis of the facial nerve","volume":"9","author":"Tsirogianni","year":"2004","journal-title":"J Peripher Nerv Syst"},{"key":"2025090411013412000_23.5.386.74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10072-009-0162-3","article-title":"A case of cranial polyneuropathy in Beh\u00e7et\u2019s disease","volume":"31","author":"Alrefai","year":"2010","journal-title":"Neurol Sci"},{"key":"2025090411013412000_23.5.386.75","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2169\/internalmedicine.49.2742","article-title":"Beh\u00e7et\u2019s disease initially presenting with meningitis and sudden hearing loss","volume":"49","author":"Kikuchi","year":"2010","journal-title":"Intern Med"},{"key":"2025090411013412000_23.5.386.76","first-page":"277","article-title":"Optic neuropathy in Beh\u00e7et\u2019s disease","volume":"9","author":"Kansu","year":"1989","journal-title":"J Clin Neuroophthalmol"},{"key":"2025090411013412000_23.5.386.77","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1007\/s00415-013-7070-4","article-title":"Optic neuropathy in Beh\u00e7et\u2019s syndrome","volume":"260","author":"Kidd","year":"2013","journal-title":"J Neurol"},{"key":"2025090411013412000_23.5.386.78","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000490","article-title":"Characteristics of optic neuropathy in Beh\u00e7et disease","volume":"5","author":"Akdal","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025090411013412000_23.5.386.79","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/WNO.0000000000000264","article-title":"Optic Perineuritis in Beh\u00e7et disease","volume":"35","author":"Lai","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"2025090411013412000_23.5.386.80","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/1352458518786058","article-title":"Primary optic neuropathy in Beh\u00e7et\u2019s syndrome","volume":"25","author":"Yang","year":"2019","journal-title":"Mult Scler"},{"key":"2025090411013412000_23.5.386.81","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1258\/0022215011908315","article-title":"Labyrinthine involvement in Beh\u00e7et\u2019s syndrome","volume":"115","author":"Pollak","year":"2001","journal-title":"J Laryngol Otol"},{"key":"2025090411013412000_23.5.386.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2004.11.020"},{"key":"2025090411013412000_23.5.386.83","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00405-019-05403-x","article-title":"Audiological and vestibular measurements in Beh\u00e7et\u2019s disease","volume":"276","author":"Ertugrul","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025090411013412000_23.5.386.84","doi-asserted-by":"publisher","DOI":"10.1007\/BF00313774"},{"key":"2025090411013412000_23.5.386.85","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200007)15:4<741::AID-MDS1025>3.0.CO;2-5"},{"key":"2025090411013412000_23.5.386.86","first-page":"45","article-title":"A case of neuro-Beh\u00e7et\u2019s disease presenting with chorea","volume":"41","author":"Kimura","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"2025090411013412000_23.5.386.87","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10067-004-0897-4","article-title":"Neuro-Beh\u00e7et\u2019s disease with chorea after remission of intestinal Beh\u00e7et\u2019s disease","volume":"23","author":"Kuriwaka","year":"2004","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.88","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5152\/npa.2015.7316","article-title":"Neuro-Beh\u00e7et\u2019s disease with chorea","volume":"52","author":"G\u00fcr \u00d6zmen","year":"2015","journal-title":"Noro Psikiyatr Ars"},{"key":"2025090411013412000_23.5.386.89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000047979","article-title":"Paroxysmal focal dystonia in neuro-Beh\u00e7et by a small ipsilateral thalamic lesion","volume":"47","author":"Guak","year":"2002","journal-title":"Eur Neurol"},{"key":"2025090411013412000_23.5.386.90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNO.0000000000000159","article-title":"Neuro-Beh\u00e7et disease presenting with Oculopalatal tremor","volume":"35","author":"Morgan","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"2025090411013412000_23.5.386.91","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000435804","article-title":"Neuro-Beh\u00e7et: Pons involvement with longitudinal extension to Midbrain and hypertrophic Olivary degeneration","volume":"7","author":"Franco-Mac\u00edas","year":"2015","journal-title":"Case Rep Neurol"},{"key":"2025090411013412000_23.5.386.92","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S0317167100033552","article-title":"Parkinsonian syndrome as a neurological manifestation of Beh\u00e7et\u2019s disease","volume":"25","author":"Bogdanova","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"2025090411013412000_23.5.386.93","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.60.3.517","article-title":"Multifocal Myelitis in Beh\u00e7et\u2019s disease","volume":"60","author":"Moskau","year":"2003","journal-title":"Neurology"},{"key":"2025090411013412000_23.5.386.94","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204366","article-title":"Treatment of Myelitis in Beh\u00e7et\u2019s disease with Rituximab","volume":"2014","author":"Messina","year":"2014","journal-title":"BMJ Case Rep"},{"key":"2025090411013412000_23.5.386.95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01754.x"},{"key":"2025090411013412000_23.5.386.96","doi-asserted-by":"publisher","DOI":"10.1179\/2045772311Y.0000000050"},{"issue":"3 Suppl 77","key":"2025090411013412000_23.5.386.97","first-page":"20","article-title":"Transverse Myelitis in Beh\u00e7et\u2019s disease: a series of four cases and review of the literature","volume":"31","author":"Bitik","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.98","doi-asserted-by":"publisher","DOI":"10.1179\/2045772314Y.0000000209"},{"key":"2025090411013412000_23.5.386.99","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515613642"},{"key":"2025090411013412000_23.5.386.100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.25004","article-title":"Myelopathy in Beh\u00e7et\u2019s disease: the Bagel sign","volume":"82","author":"Uygunoglu","year":"2017","journal-title":"Ann Neurol"},{"key":"2025090411013412000_23.5.386.101","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007958","article-title":"Clinical and imaging features of spinal cord type of neuro Beh\u00e7et disease: A case report and systematic review","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025090411013412000_23.5.386.102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09938-z","article-title":"Distinct clinical features between acute and chronic progressive Parenchymal neuro-Beh\u00e7et disease: meta-analysis","volume":"7","author":"Ishido","year":"2017","journal-title":"Sci Rep"},{"key":"2025090411013412000_23.5.386.103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archderm.1944.01510100003001","article-title":"Beh\u00e7et\u2019s syndrome with involvement of the central nervous system","volume":"49","author":"Berlin","year":"1944","journal-title":"Arch Derm Syphilol"},{"key":"2025090411013412000_23.5.386.104","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(57)92590-4","article-title":"Encephalomyelopathy in Beh\u00e7et\u2019s disease: report of necropsy findings in two cases","volume":"273","author":"McMENEMEY","year":"1957","journal-title":"Lancet"},{"key":"2025090411013412000_23.5.386.105","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/86.1.151"},{"key":"2025090411013412000_23.5.386.106","first-page":"95","article-title":"Neuro-Beh\u00e7et\u2019s syndrome: report of two autopsy cases","volume":"19","author":"Sugihara","year":"1969","journal-title":"Acta Pathol Jpn"},{"key":"2025090411013412000_23.5.386.107","doi-asserted-by":"publisher","DOI":"10.1007\/BF00684660"},{"key":"2025090411013412000_23.5.386.108","first-page":"208","article-title":"Neuro-Beh\u00e7et disease with Demyelination and Gliosis of the frontal white matter","volume":"13","author":"Yamamori","year":"1994","journal-title":"Clin Neuropathol"},{"key":"2025090411013412000_23.5.386.109","first-page":"249","article-title":"Neuro-Beh\u00e7et\u2019s disease","volume":"15","author":"Hadfield","year":"1996","journal-title":"Clin Neuropathol"},{"key":"2025090411013412000_23.5.386.110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1789.2006.00734.x"},{"key":"2025090411013412000_23.5.386.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2007.09.041"},{"key":"2025090411013412000_23.5.386.112","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/j.1468-1331.2012.03738.x","article-title":"Reversible cerebral Venulitis in a patient with neuro-Behcet disease","volume":"19","author":"Kumral","year":"2012","journal-title":"Eur J Neurol"},{"key":"2025090411013412000_23.5.386.113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10067-017-3718-2","article-title":"Cerebral venous sinus thrombosis in Beh\u00e7et\u2019s disease: a retrospective case-control study","volume":"37","author":"Shi","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.114","doi-asserted-by":"publisher","DOI":"10.1002\/art.24393"},{"key":"2025090411013412000_23.5.386.115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/rheumatology\/key153","article-title":"Beh\u00e7et\u2019s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study","volume":"58","author":"Uluduz","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2025090411013412000_23.5.386.116","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","article-title":"Cerebral venous thrombosis in Beh\u00e7et\u2019s disease compared to those associated with other Etiologies","volume":"256","author":"Yesilot","year":"2009","journal-title":"J Neurol"},{"key":"2025090411013412000_23.5.386.117","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5606\/ArchRheumatol.2016.5749","article-title":"Cerebral venous thrombosis in Beh\u00e7et\u2019s disease patients compared to other causes of cerebral venous thrombosis: a retrospective study","volume":"31","author":"Sorgun","year":"2016","journal-title":"Arch Rheumatol"},{"key":"2025090411013412000_23.5.386.118","first-page":"147","article-title":"Paediatric Beh\u00e7et\u2019s disease with sinus venous thrombosis: experience from three centres in Turkey","volume":"37 Suppl 121","author":"Demir","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227836","article-title":"Prevalence of Antiphospholipid antibodies in Beh\u00e7et\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Islam","year":"2020","journal-title":"PLoS One"},{"key":"2025090411013412000_23.5.386.120","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.614"},{"key":"2025090411013412000_23.5.386.121","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2017.10.038","article-title":"Pseudotumor Cerebri syndrome without cerebral venous sinus thrombosis in Beh\u00e7et's disease","volume":"383","author":"Akdal","year":"2017","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.122","first-page":"832","article-title":"Beh\u00e7et\u2019s disease with multiple intracranial arterial aneurysms","volume":"143","author":"Buge","year":"1987","journal-title":"Rev Neurol (Paris)"},{"key":"2025090411013412000_23.5.386.123","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2001.00300.x"},{"key":"2025090411013412000_23.5.386.124","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/anr.1780320217","article-title":"Central nervous system vasculitis in Beh\u00e7et\u2019s syndrome: angiographic improvement after therapy with cytotoxic agents","volume":"32","author":"Zelenski","year":"1989","journal-title":"Arthritis Rheum"},{"key":"2025090411013412000_23.5.386.125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10072-006-0568-2","article-title":"An unusual case of neuro-Beh\u00e7et\u2019s disease presenting with reversible basilar artery occlusion","volume":"27","author":"Lee","year":"2006","journal-title":"Neurol Sci"},{"key":"2025090411013412000_23.5.386.126","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/j.1468-1331.2007.01822.x","article-title":"A case of neuro-Vasculo-Behcet disease","volume":"14","author":"Gan","year":"2007","journal-title":"Eur J Neurol"},{"key":"2025090411013412000_23.5.386.127","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10072-012-1122-x","article-title":"An unusual case of neuro-Beh\u00e7et\u2019s disease presenting with Co-occurrence of cerebral venous sinus thrombosis with basilar artery occlusion","volume":"34","author":"Tascilar","year":"2013","journal-title":"Neurol Sci"},{"key":"2025090411013412000_23.5.386.128","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(91)90188-D"},{"key":"2025090411013412000_23.5.386.129","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01102","article-title":"Beh\u00e7et\u2019s disease with cerebral artery infarction caused by cerebral arteritis as an early symptom only with elevated Interleukin-8","volume":"10","author":"Yin","year":"2019","journal-title":"Front Neurol"},{"key":"2025090411013412000_23.5.386.130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7461\/jcen.2016.18.1.32","article-title":"Multiple intracranial aneurysms associated with Beh\u00e7et\u2019s disease","volume":"18","author":"Ha","year":"2016","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"2025090411013412000_23.5.386.131","first-page":"234","article-title":"Unruptured multiple intracranial aneurysms associated with Beh\u00e7et\u2019s disease","volume":"42","author":"Belfeki","year":"2017","journal-title":"J Med Vasc"},{"key":"2025090411013412000_23.5.386.132","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00701-007-1226-x","article-title":"Multiple peripheral middle cerebral artery aneurysms associated with Beh\u00e7et\u2019s disease","volume":"149","author":"Kaku","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"key":"2025090411013412000_23.5.386.133","doi-asserted-by":"publisher","DOI":"10.1007\/BF00588368"},{"key":"2025090411013412000_23.5.386.134","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s100169900185","article-title":"Internal carotid artery dissection in a patient with Beh\u00e7et\u2019s syndrome","volume":"12","author":"Pannone","year":"1998","journal-title":"Annals of Vascular Surgery"},{"key":"2025090411013412000_23.5.386.135","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/acn3.773","article-title":"Vertebral artery dissection associated with familial Mediterranean fever and Beh\u00e7et\u2019s disease","volume":"6","author":"Ishikawa","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2025090411013412000_23.5.386.136","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.2.190"},{"key":"2025090411013412000_23.5.386.137","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2169\/internalmedicine.41.692","article-title":"Intracranial haemorrhage in neuro-Beh\u00e7et\u2019s syndrome","volume":"41","author":"Kikuchi","year":"2002","journal-title":"Intern Med"},{"key":"2025090411013412000_23.5.386.138","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13256-016-1151-9","article-title":"Neuro-Beh\u00e7et disease presenting as a solitary cerebellar hemorrhagic lesion: a case report and review of the literature","volume":"10","author":"Yeo","year":"2016","journal-title":"J Med Case Reports"},{"key":"2025090411013412000_23.5.386.139","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00415-016-8363-1","article-title":"Delayed symptomatic intracerebral hemorrhages in neuro-Beh\u00e7et\u2019s disease","volume":"264","author":"Lee","year":"2017","journal-title":"J Neurol"},{"key":"2025090411013412000_23.5.386.140","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2169\/internalmedicine.8632-16","article-title":"Multiple hemorrhagic cerebral cortical lesions in neuro-Beh\u00e7et\u2019s disease","volume":"56","author":"Saito","year":"2017","journal-title":"Intern Med"},{"key":"2025090411013412000_23.5.386.141","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1528-1157.2002.01102.x","article-title":"Epileptic seizures in Beh\u00e7et disease","volume":"43","author":"Aykutlu","year":"2002","journal-title":"Epilepsia"},{"key":"2025090411013412000_23.5.386.142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.07.053","article-title":"Epilepsy and Beh\u00e7et\u2019s disease: cortical and hippocampal involvement in Brazilian patients","volume":"309","author":"Dutra","year":"2011","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.143","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.3.392"},{"key":"2025090411013412000_23.5.386.144","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.clineuro.2004.12.021","article-title":"Epilepsia Partialis Continua in a patient with Beh\u00e7et\u2019s disease","volume":"108","author":"Aktekin","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"2025090411013412000_23.5.386.145","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s11065-019-09416-5","article-title":"A systematic review of Neurocognitive functioning in Beh\u00e7et\u2019s disease","volume":"29","author":"Fisher","year":"2019","journal-title":"Neuropsychol Rev"},{"key":"2025090411013412000_23.5.386.146","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050317"},{"key":"2025090411013412000_23.5.386.147","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04670.x"},{"key":"2025090411013412000_23.5.386.148","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2004.02.021","article-title":"Cognitive impairment in Beh\u00e7et\u2019s disease patients without overt neurological involvement","volume":"220","author":"Monastero","year":"2004","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.01.024","article-title":"Cognitive impairment in Brazilian patients with Beh\u00e7et\u2019s disease occurs independently of neurologic manifestation","volume":"327","author":"Dutra","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"key":"2025090411013412000_23.5.386.150","first-page":"511","article-title":"Cognitive impairment not only in neuroBehcet but also for all Behcet disease phenotypes","volume":"31","author":"Sucullu-Karadag","year":"2014","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.151","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00415-004-0391-6","article-title":"P300 and neuropsychological evaluation in Beh\u00e7et\u2019s disease with and without neurological manifestations","volume":"251","author":"G\u00f6k\u00e7ay","year":"2004","journal-title":"J Neurol"},{"key":"2025090411013412000_23.5.386.152","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jns.2008.10.003","article-title":"Delayed diagnosis of a neuroBeh\u00e7et patient with only brainstem and cerebellar atrophy: literature review","volume":"277","author":"Taskapilioglu","year":"2009","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.153","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00508-013-0364-9","article-title":"Cortical and cerebellar atrophy, but no lesion in a patient with neuro-Behcet\u2019s disease","volume":"125","author":"Varoglu","year":"2013","journal-title":"Wien Klin Wochenschr"},{"key":"2025090411013412000_23.5.386.154","first-page":"S110","article-title":"Beh\u00e7et\u2019s syndrome patients have high levels of functional disability, fatigue and pain as measured by a multi-dimensional health assessment questionnaire (MDHAQ)","volume":"26","author":"Alder","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.155","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/1756-185X.12839","article-title":"Fatigue in patients with Beh\u00e7et\u2019s syndrome: relationship with quality of life, depression, anxiety, disability and disease activity","volume":"21","author":"Ilhan","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2025090411013412000_23.5.386.156","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10067-014-2632-0","article-title":"The relationship between disease activity and depression and sleep quality in Beh\u00e7et\u2019s disease patients","volume":"34","author":"Koca","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"6 Suppl 115","key":"2025090411013412000_23.5.386.157","first-page":"53","article-title":"Why are Beh\u00e7et\u2019s disease patients always exhausted","volume":"36","author":"Senusi","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.158","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40263-015-0228-0","article-title":"Epidemiology and management of neuropsychiatric disorders in Beh\u00e7et\u2019s syndrome","volume":"29","author":"Talarico","year":"2015","journal-title":"CNS Drugs"},{"key":"2025090411013412000_23.5.386.159","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s004060200008","article-title":"Neuro-Beh\u00e7et\u2019s disease involving the Pons with initial onset of affective symptoms","volume":"252","author":"Aydin","year":"2002","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2025090411013412000_23.5.386.160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/13651500410005469","article-title":"Psychiatric findings related to neurological complications in Beh\u00e7et\u2019s disease: A short review and a case presentation","volume":"8","author":"Ozdemir","year":"2004","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2025090411013412000_23.5.386.161","first-page":"564","article-title":"A case of neuro-Beh\u00e7et\u2019s disease with early onset of bipolar mood disorder","volume":"106","author":"Nakano","year":"2004","journal-title":"Seishin Shinkeigaku Zasshi"},{"issue":"3 Pt 1","key":"2025090411013412000_23.5.386.162","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0013-7006(06)77335-3","article-title":"Acute psychosis and Beh\u00e7et\u2019s disease: a case report","volume":"32","author":"Nkam","year":"2006","journal-title":"Encephale"},{"key":"2025090411013412000_23.5.386.163","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2009.07.009"},{"key":"2025090411013412000_23.5.386.164","first-page":"252","article-title":"Psychiatric disorders and MRI brain findings in patients with systemic lupus erythematosus and Beh\u00e7et\u2019s disease: a cross sectional study","volume":"38","author":"Abdelraheem","year":"2013","journal-title":"Acta Reumatol Port"},{"key":"2025090411013412000_23.5.386.165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/0883073813504137","article-title":"Neuro-Beh\u00e7et disease presenting with acute psychosis in an adolescent","volume":"29","author":"Patel","year":"2014","journal-title":"J Child Neurol"},{"key":"2025090411013412000_23.5.386.166","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/13554794.2016.1186701","article-title":"Chronic behavior disturbance and Neurocognitive deficits in neuro-Beh\u00e7et\u2019s disease: a case study","volume":"22","author":"Fisher","year":"2016","journal-title":"Neurocase"},{"key":"2025090411013412000_23.5.386.167","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/13554794.2018.1561898","article-title":"Neuro-Beh\u00e7et\u2019s disease presenting as an isolated progressive cognitive and behavioural syndrome","volume":"24","author":"Saracino","year":"2018","journal-title":"Neurocase"},{"key":"2025090411013412000_23.5.386.168","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0895-6111(92)90059-I","article-title":"CNS changes in neuro-Beh\u00e7et\u2019s disease: CT, MR, and SPECT findings","volume":"16","author":"Mizukami","year":"1992","journal-title":"Comput Med Imaging Graph"},{"key":"2025090411013412000_23.5.386.169","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00812151","article-title":"rCBF abnormalities detected, and Sequentially followed, by SPECT in neuro-Beh\u00e7et\u2019s syndrome with normal CT and MRI imaging","volume":"239","author":"Markus","year":"1992","journal-title":"J Neurol"},{"key":"2025090411013412000_23.5.386.170","first-page":"1707","article-title":"Technetium-99M-HMPAO SPECT and MRI of brain in patients with neuro-Beh\u00e7et\u2019s syndrome","volume":"39","author":"Kao","year":"1998","journal-title":"J Nucl Med"},{"key":"2025090411013412000_23.5.386.171","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1552-6569.2002.tb00144.x","article-title":"Decreased cerebral blood flow in neuro-Beh\u00e7et\u2019s syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging--a preliminary report","volume":"12","author":"Huang","year":"2002","journal-title":"J Neuroimaging"},{"key":"2025090411013412000_23.5.386.172","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10067-011-1725-2","article-title":"Silent central nervous system involvement in Egyptian Beh\u00e7et\u2019s disease patients: clinical, psychiatric, and neuroimaging evaluation","volume":"30","author":"Zayed","year":"2011","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.173","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.neurad.2013.01.001","article-title":"Brain perfusion SPECT in patients with Beh\u00e7et's disease","volume":"40","author":"Chuang","year":"2013","journal-title":"J Neuroradiol"},{"key":"2025090411013412000_23.5.386.174","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/1947-2714.156008","article-title":"Role of brain perfusion SPECT with 99Mtc HMPAO in the assessment of response to drug therapy in patients with autoimmune vasculitis: A prospective study","volume":"7","author":"Mauro","year":"2015","journal-title":"N Am J Med Sci"},{"key":"2025090411013412000_23.5.386.175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/0-306-48382-3_76","article-title":"The prevalence of headache in Beh\u00e7et\u2019s syndrome","volume":"528","author":"Kidd","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"2025090411013412000_23.5.386.176","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00476.x"},{"key":"2025090411013412000_23.5.386.177","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1526-4610.2005.05160.x","article-title":"Headache in Beh\u00e7et\u2019s syndrome","volume":"45","author":"Saip","year":"2005","journal-title":"Headache"},{"key":"2025090411013412000_23.5.386.178","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei255"},{"key":"2025090411013412000_23.5.386.179","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.01017.x"},{"key":"2025090411013412000_23.5.386.180","doi-asserted-by":"crossref","DOI":"10.1186\/s40064-016-2721-4","article-title":"Headache in Beh\u00e7et\u2019s disease: types and characteristics","volume":"5","author":"Moghaddassi","year":"2016","journal-title":"SpringerPlus"},{"key":"2025090411013412000_23.5.386.181","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-75-4-561"},{"key":"2025090411013412000_23.5.386.182","first-page":"519","article-title":"Biopsy study of the peripheral nerves in neuro-Beh\u00e7et\u2019s syndrome","volume":"14","author":"Wakayama","year":"1974","journal-title":"Rinsho Shinkeigaku"},{"key":"2025090411013412000_23.5.386.183","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000116342","article-title":"Peripheral nervous system involvement in Beh\u00e7et\u2019s disease","volume":"26","author":"Namer","year":"1987","journal-title":"Eur Neurol"},{"key":"2025090411013412000_23.5.386.184","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0035-3787(05)85026-X","article-title":"Beh\u00e7et\u2019s disease associated with peripheral neuropathy","volume":"161","author":"Ben Ghorbel","year":"2005","journal-title":"Rev Neurol (Paris)"},{"key":"2025090411013412000_23.5.386.185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02030351","article-title":"Mononeuritis Multiplex in incomplete Beh\u00e7et\u2019s disease: a case report and the review of the literature","volume":"8","author":"Takeuchi","year":"1989","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.186","first-page":"206","article-title":"Beh\u00e7et\u2019s disease presenting with Mononeuritis Multiplex","volume":"59","author":"Walker","year":"1990","journal-title":"Ulster Med J"},{"key":"2025090411013412000_23.5.386.187","first-page":"520","article-title":"Polyradiculonevrite au Cours D\u2019Une Poussee Evolutive de Maladie de Behcet","volume":"140","author":"Bakouche","year":"1984","journal-title":"Rev Neurol (Paris)"},{"key":"2025090411013412000_23.5.386.188","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neurol.2017.08.007","article-title":"Acute Polyradiculoneuritis revealing Behcet\u2019s disease","volume":"174","author":"Benzakour","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"2025090411013412000_23.5.386.189","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/art.1780230512","article-title":"Behcet syndrome with Myositis: a case report with Pathologic findings","volume":"23","author":"Arkin","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2025090411013412000_23.5.386.190","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.1780330317","article-title":"Pediatric onset of Beh\u00e7et\u2019s syndrome with Myositis: case report and literature review illustrating unusual features","volume":"33","author":"Lang","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025090411013412000_23.5.386.191","doi-asserted-by":"publisher","DOI":"10.1007\/s004310051320"},{"key":"2025090411013412000_23.5.386.192","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.8.751"},{"key":"2025090411013412000_23.5.386.193","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2010.03082.x"},{"key":"2025090411013412000_23.5.386.194","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker450"},{"key":"2025090411013412000_23.5.386.195","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-211983","article-title":"A rare case of Beh\u00e7et disease with generalised Myositis, Cardiomyositis and Necrotising Fasciitis","volume":"2016","author":"Ng","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2025090411013412000_23.5.386.196","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70368-3"},{"key":"2025090411013412000_23.5.386.197","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-016-0070-z","article-title":"Beh\u00e7et\u2019s disease in children, an overview","volume":"14","author":"Kon\u00e9-Paut","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2025090411013412000_23.5.386.198","first-page":"48","article-title":"Comparing the clinical profile of adults and children with Beh\u00e7et\u2019s syndrome in the UK","volume":"37 Suppl 121","author":"Makmur","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.199","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1269909"},{"key":"2025090411013412000_23.5.386.200","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318238edeb"},{"issue":"4 Suppl 84","key":"2025090411013412000_23.5.386.201","first-page":"S165","article-title":"Clinical characteristics of Paediatric neuro-Beh\u00e7et\u2019s disease: a single tertiary centre experience","volume":"32","author":"Cakar","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl 77","key":"2025090411013412000_23.5.386.202","first-page":"25","article-title":"Intrathecal Oligoclonal IgG bands are infrequently found in neuro-Beh\u00e7et\u2019s disease","volume":"31","author":"Saruhan-Direskeneli","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.203","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2169\/internalmedicine.51.8583","article-title":"Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Beh\u00e7et\u2019s disease","volume":"51","author":"Hirohata","year":"2012","journal-title":"Intern Med"},{"key":"2025090411013412000_23.5.386.204","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.10.007"},{"key":"2025090411013412000_23.5.386.205","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2009.02.001"},{"key":"2025090411013412000_23.5.386.206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2015.01.005","article-title":"Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet's disease","volume":"349","author":"Hirohata","year":"2015","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2003.08.040"},{"key":"2025090411013412000_23.5.386.208","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/acn3.538","article-title":"CSF\/serum matrix Metallopeptidase-9 ratio discriminates neuro Beh\u00e7et from multiple sclerosis","volume":"5","author":"Aldinucci","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2025090411013412000_23.5.386.209","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cyto.2018.03.039","article-title":"Cerebrospinal fluid IL-10 as an early stage Discriminative marker between multiple sclerosis and neuro-Beh\u00e7et disease","volume":"108","author":"Belghith","year":"2018","journal-title":"Cytokine"},{"key":"2025090411013412000_23.5.386.210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-3083.2012.02694.x","article-title":"Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Beh\u00e7et\u2019s disease: BAFF is correlated with progressive dementia and psychosis","volume":"75","author":"Sumita","year":"2012","journal-title":"Scand J Immunol"},{"key":"2025090411013412000_23.5.386.211","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.3.405"},{"key":"2025090411013412000_23.5.386.212","doi-asserted-by":"publisher","DOI":"10.1159\/000116956"},{"key":"2025090411013412000_23.5.386.213","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.7.793"},{"key":"2025090411013412000_23.5.386.214","first-page":"1015","article-title":"CNS involvement in neuro-Beh\u00e7et syndrome: an MR study","volume":"20","author":"Ko\u00e7er","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411013412000_23.5.386.215","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-003-1102-1"},{"key":"2025090411013412000_23.5.386.216","doi-asserted-by":"publisher","DOI":"10.1053\/crad.2000.0675"},{"key":"2025090411013412000_23.5.386.217","doi-asserted-by":"publisher","DOI":"10.1007\/s002340050356"},{"key":"2025090411013412000_23.5.386.218","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1212\/WNL.39.9.1251","article-title":"Beh\u00e7et\u2019s disease with slowly enlarging Midbrain mass on MRI: resolution following steroid therapy","volume":"39","author":"Kermode","year":"1989","journal-title":"Neurology"},{"key":"2025090411013412000_23.5.386.219","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3346\/jkms.2002.17.5.718","article-title":"Neuro-Beh\u00e7et\u2019s disease mimicking a cerebral tumor: a case report","volume":"17","author":"Park","year":"2002","journal-title":"J Korean Med Sci"},{"key":"2025090411013412000_23.5.386.220","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2169\/internalmedicine.51.6789","article-title":"Ring-enhanced brainstem lesion in a patient with neuro-Beh\u00e7et\u2019s disease","volume":"51","author":"Yasuda","year":"2012","journal-title":"Intern Med"},{"key":"2025090411013412000_23.5.386.221","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5152\/eurjrheum.2014.007","article-title":"Mass-like lesions as a rare form of neuro-Beh\u00e7et\u2019s disease: a case report and review of the literature","volume":"1","author":"Bilge","year":"2014","journal-title":"Eur J Rheumatol"},{"key":"2025090411013412000_23.5.386.222","doi-asserted-by":"publisher","DOI":"10.1007\/s002340050343"},{"key":"2025090411013412000_23.5.386.223","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.45.1614"},{"key":"2025090411013412000_23.5.386.224","first-page":"1612","article-title":"Neuro-Behcet\u2019s disease: diffusion MR imaging and proton MR spectroscopy","volume":"24","author":"Sener","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025090411013412000_23.5.386.225","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.3.412"},{"key":"2025090411013412000_23.5.386.226","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2477"},{"key":"2025090411013412000_23.5.386.227","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2012.04.040","article-title":"Brain stem and cerebellar atrophy in chronic progressive neuro-Beh\u00e7et's disease","volume":"82","author":"Kanoto","year":"2013","journal-title":"Eur J Radiol"},{"key":"2025090411013412000_23.5.386.228","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jns.2013.11.020","article-title":"Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Beh\u00e7et's disease","volume":"337","author":"Kikuchi","year":"2014","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.229","doi-asserted-by":"publisher","DOI":"10.1007\/s002340050837"},{"issue":"6 Suppl 94","key":"2025090411013412000_23.5.386.230","first-page":"S80","article-title":"Beh\u00e7et\u2019s disease patients with multiple sclerosis-like features: Discriminative value of Barkhof criteria","volume":"33","author":"Akman-Demir","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.231","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/j.jinf.2005.07.026","article-title":"Neuro-Beh\u00e7et syndrome presenting as acute Meningeal syndrome","volume":"52","author":"Kara","year":"2006","journal-title":"J Infect"},{"key":"2025090411013412000_23.5.386.232","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5607\/en.2015.24.3.252","article-title":"Neuro-Beh\u00e7et\u2019s disease presenting as hypertrophic Pachymeningitis","volume":"24","author":"Yoon","year":"2015","journal-title":"Exp Neurobiol"},{"key":"2025090411013412000_23.5.386.233","first-page":"e644","article-title":"Neuro-Beh\u00e7et disease presented with Pachymeningitis in a child","volume":"117","author":"Alkan","year":"2019","journal-title":"Arch Argent Pediatr"},{"key":"2025090411013412000_23.5.386.234","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003863","article-title":"Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study","volume":"95","author":"Hibi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025090411013412000_23.5.386.235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5692\/clinicalneurol.cn-001086","article-title":"A case of chronic progressive neuro-Beh\u00e7et disease with extensive cerebral atrophy and elevated CSF IL-6 activity treated with Infliximab","volume":"58","author":"Hamada","year":"2018","journal-title":"Rinsho Shinkeigaku"},{"key":"2025090411013412000_23.5.386.236","article-title":"Biologics, Colchicine, corticosteroids, immunosuppressants and interferon-alpha for neuro-Beh\u00e7et\u2019s syndrome","volume":"12","author":"Nava","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090411013412000_23.5.386.237","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.05.008"},{"key":"2025090411013412000_23.5.386.238","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/BOR.0000000000000497","article-title":"Management of Beh\u00e7et\u2019s disease","volume":"30","author":"Alibaz-Oner","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"2025090411013412000_23.5.386.239","doi-asserted-by":"crossref","first-page":"annrheumdis","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"Update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025090411013412000_23.5.386.240","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/rheumatology\/key242","article-title":"Management of major organ involvement of Beh\u00e7et\u2019s syndrome: a systematic review for update of the EULAR recommendations","volume":"57","author":"Ozguler","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025090411013412000_23.5.386.241","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90120-3"},{"key":"2025090411013412000_23.5.386.242","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-9071.2001.00445.x"},{"key":"2025090411013412000_23.5.386.243","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0070-8"},{"issue":"4 Suppl 50","key":"2025090411013412000_23.5.386.244","first-page":"S84","article-title":"Cyclosporine for Beh\u00e7et\u2019s uveitis: is it associated with an increased risk of neurological involvement","volume":"26","author":"Akman-Demir","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 2","key":"2025090411013412000_23.5.386.245","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/annrheumdis-2016-eular.2780","article-title":"Ab0545 interferon Alpha2A versus Cyclosporin A for the treatment of severe ocular Beh\u00e7et\u2019s disease\u2014a prospective, randomised, single blind, national multicenter trial (INCYTOB)","volume":"75","author":"K\u00f6tter","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025090411013412000_23.5.386.246","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09273948.2017.1384026","article-title":"Long-term efficacy and safety of interferon Alpha-2A in the treatment of Chinese patients with Beh\u00e7et\u2019s uveitis not responding to conventional therapy","volume":"27","author":"Yang","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090411013412000_23.5.386.247","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05497-6"},{"key":"2025090411013412000_23.5.386.248","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/09273948.2019.1606256","article-title":"Comparison of the treatment results for Beh\u00e7et uveitis in patients treated with Infliximab and interferon","volume":"28","author":"Yal\u00e7indag","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090411013412000_23.5.386.249","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-018-0929-5","article-title":"Conventional immunosuppressive therapy in severe Beh\u00e7et\u2019s uveitis: the switch rate to the biological agents","volume":"18","author":"Celiker","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"2025090411013412000_23.5.386.250","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.12.005"},{"key":"2025090411013412000_23.5.386.251","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.09.002"},{"key":"2025090411013412000_23.5.386.252","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et's disease: multicenter study of 124 patients","volume":"62","author":"Vallet","year":"2015","journal-title":"J Autoimmun"},{"key":"2025090411013412000_23.5.386.253","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000258","article-title":"Infliximab is a plausible alternative for neurologic complications of Beh\u00e7et disease","volume":"3","author":"Zeydan","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025090411013412000_23.5.386.254","doi-asserted-by":"crossref","unstructured":"Hirohata S , Kikuchi H , Sawada T , et al . Effect of Infliximab on chronic progressive Behcet\u2019s disease: influence of the timing of introduction on the patient outcome. Intern Med 2023:23. doi:10.2169\/internalmedicine.1969-23","DOI":"10.2169\/internalmedicine.1969-23"},{"key":"2025090411013412000_23.5.386.255","doi-asserted-by":"crossref","unstructured":"Ahn JK , Cha HS , Koh EM , et al . n.d. Behcet\u2019s disease associated with bone marrow failure in Korean patients: clinical characteristics and the Association of intestinal ulceration and Trisomy 8. Rheumatology;47:1228\u201330. doi:10.1093\/rheumatology\/ken162","DOI":"10.1093\/rheumatology\/ken162"},{"key":"2025090411013412000_23.5.386.256","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket479"},{"key":"2025090411013412000_23.5.386.257","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4902941","article-title":"High incidence of gastrointestinal ulceration and Cytogenetic aberration of Trisomy 8 as typical features of Beh\u00e7et\u2019s disease associated with myelodysplastic syndrome: A series of 16 consecutive Chinese patients from the Shanghai Beh\u00e7et\u2019s disease database and comparison with the literature","volume":"2018","author":"Shen","year":"2018","journal-title":"BioMed Research International"},{"key":"2025090411013412000_23.5.386.258","doi-asserted-by":"crossref","first-page":"100196","DOI":"10.1016\/j.lrr.2020.100196","article-title":"The acquisition of Trisomy 8 associated with Beh\u00e7et\u2019S-like disease in myelodysplastic syndrome","volume":"13","author":"Oka","year":"2020","journal-title":"Leukemia Research Reports"},{"key":"2025090411013412000_23.5.386.259","article-title":"Switching to Adalimumab is effective in a case of neuro-Beh\u00e7et\u2019s disease refractory to Infliximab","volume":"28","author":"Leccese","year":"2010","journal-title":"Clin Exp Rheumaol"},{"key":"2025090411013412000_23.5.386.260","first-page":"367","article-title":"Severe neuro-Beh\u00e7et\u2019s disease treated with a combination of Immunosuppressives and a TNF-inhibitor","volume":"41","author":"Korkmaz","year":"2016","journal-title":"Acta Reumatol Port"},{"key":"2025090411013412000_23.5.386.261","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705372"},{"key":"2025090411013412000_23.5.386.262","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056630"},{"key":"2025090411013412000_23.5.386.263","doi-asserted-by":"publisher","DOI":"10.1177\/039463200702000110"},{"key":"2025090411013412000_23.5.386.264","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070227"},{"key":"2025090411013412000_23.5.386.265","doi-asserted-by":"crossref","unstructured":"Chadwick L , Thong D , Nair J , et al . Autologous stem cell transplantation in the management of refractory Beh\u00e7et\u2019s syndrome: a case series of a single centre of excellence, Available: https:\/\/ard.bmj.com\/content\/76\/suppl2\/1251.2","DOI":"10.1136\/annrheumdis-2017-eular.4745"},{"key":"2025090411013412000_23.5.386.266","doi-asserted-by":"publisher","DOI":"10.1002\/art.34450"},{"key":"2025090411013412000_23.5.386.267","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000494","article-title":"Beh\u00e7et disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025090411013412000_23.5.386.268","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/art.40531","article-title":"Adalimumab-based treatment versus disease-modifying Antirheumatic drugs for venous thrombosis in Beh\u00e7et\u2019s syndrome: A retrospective study of seventy patients with vascular involvement","volume":"70","author":"Emmi","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025090411013412000_23.5.386.269","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0685-z"},{"key":"2025090411013412000_23.5.386.270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2018.08.004","article-title":"Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Beh\u00e7et\u2019s disease: A multicenter observational study of 18 patients","volume":"197","author":"Desbois","year":"2018","journal-title":"Clin Immunol"},{"key":"2025090411013412000_23.5.386.271","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","article-title":"Vascular Beh\u00e7et\u2019s syndrome: an update","volume":"14","author":"Emmi","year":"2019","journal-title":"Intern Emerg Med"},{"key":"2025090411013412000_23.5.386.272","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1756-185X.13778","article-title":"Efficacy of TNF\u03b1 inhibitors for refractory vascular Beh\u00e7et\u2019s disease: a Multicentre observational study of 27 patients and a review of the literature","volume":"23","author":"Aksoy","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2025090411013412000_23.5.386.273","first-page":"303","article-title":"Efficacy and safety of anti-tumor necrosis factor \u0391 Monoclonal antibodies in 16 patients with severe\/refractory Vasculo Beh\u00e7et\u2019s disease","volume":"59","author":"Li","year":"2020","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2025090411013412000_23.5.386.274","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/1756-185X.13298","article-title":"Management of vascular Beh\u00e7et\u2019s disease","volume":"22 Suppl 1","author":"Alibaz-Oner","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2025090411013412000_23.5.386.275","first-page":"2057","article-title":"Tocilizumab in the treatment of severe and\/or refractory Vasculo-Beh\u00e7et\u2019s disease: a single-centre experience in China","volume":"57","author":"Ding","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025090411013412000_23.5.386.276","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01065","article-title":"Primary Immunodeficiencies with defects in innate immunity: focus on orofacial manifestations","volume":"11","author":"Jung","year":"2020","journal-title":"Front Immunol"},{"key":"2025090411013412000_23.5.386.277","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.3.280"},{"key":"2025090411013412000_23.5.386.278","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.055434"},{"key":"2025090411013412000_23.5.386.279","first-page":"181","article-title":"Successful treatment of longstanding neuro-Beh\u00e7et\u2019s disease with Infliximab","volume":"32","author":"Sarwar","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090411013412000_23.5.386.280","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.056804"},{"key":"2025090411013412000_23.5.386.281","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2007.10.005"},{"key":"2025090411013412000_23.5.386.282","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.05.002"},{"key":"2025090411013412000_23.5.386.283","doi-asserted-by":"publisher","DOI":"10.1002\/art.23345"},{"key":"2025090411013412000_23.5.386.284","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2009.01420.x"},{"key":"2025090411013412000_23.5.386.285","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/s10165-010-0332-4","article-title":"An attack of acute neuro-Beh\u00e7et\u2019s disease during the course of chronic progressive neuro-Beh\u00e7et\u2019s disease: report of two cases","volume":"20","author":"Matsui","year":"2010","journal-title":"Modern Rheumatology"},{"key":"2025090411013412000_23.5.386.286","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10067-011-1726-1","article-title":"Infliximab for patients with neuro-Beh\u00e7et\u2019s disease: case series and literature review","volume":"30","author":"Borhani Haghighi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.287","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5692\/clinicalneurol.51.261","article-title":"Infliximab treatment trial in a patient with neuro-Beh\u00e7et\u2019s disease unresponsive to other treatments","volume":"51","author":"Kadowaki","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"key":"2025090411013412000_23.5.386.288","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2011.08.014","article-title":"Infliximab monotherapy in neuro-Beh\u00e7et\u2019s disease: four year follow up in a long standing case resistant to conventional therapies","volume":"239","author":"Fasano","year":"2011","journal-title":"Journal of Neuroimmunology"},{"key":"2025090411013412000_23.5.386.289","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1213-z"},{"key":"2025090411013412000_23.5.386.290","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7150-5"},{"key":"2025090411013412000_23.5.386.291","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/1346-8138.12203","article-title":"Case of neuro-Beh\u00e7et\u2019s disease successfully maintained a remission using Infliximab for 2 years","volume":"40","author":"Kanemaru","year":"2013","journal-title":"J Dermatol"},{"key":"2025090411013412000_23.5.386.292","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12297"},{"key":"2025090411013412000_23.5.386.293","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jns.2014.09.052","article-title":"Infliximab monotherapy for neuro-Beh\u00e7et\u2019s disease: a case report","volume":"347","author":"Di Filippo","year":"2014","journal-title":"J Neurol Sci"},{"key":"2025090411013412000_23.5.386.294","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5692\/clinicalneurol.54.16","article-title":"A case of neuro-Beh\u00e7et disease presenting with a longitudinal spinal cord lesion without pain","volume":"54","author":"Sakuta","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"key":"2025090411013412000_23.5.386.295","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003550","article-title":"Efficacy of TNF\u03b1 in severe and refractory neuro-Beh\u00e7et\u2019s disease","volume":"95","author":"Desbois","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025090411013412000_23.5.386.296","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00296-018-4054-9","article-title":"Improvement of neurological and ocular symptoms of Beh\u00e7et\u2019s disease after the introduction of Infliximab","volume":"38","author":"Bare\u0161i\u0107","year":"2018","journal-title":"Rheumatol Int"},{"issue":"4 Suppl 50","key":"2025090411013412000_23.5.386.297","first-page":"S133","article-title":"Efficacy of Infliximab and Adalimumab in the treatment of a patient with severe neuro-Beh\u00e7et\u2019s disease","volume":"26","author":"Belzunegui","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.298","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pediatrneurol.2010.04.021","article-title":"Pediatric neuro-Beh\u00e7et\u2019s disease responsive to Adalimumab","volume":"43","author":"Robinson","year":"2010","journal-title":"Pediatr Neurol"},{"key":"2025090411013412000_23.5.386.299","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2006.11.002"},{"key":"2025090411013412000_23.5.386.300","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10067-017-3627-4","article-title":"Long term efficacy and safety of Golimumab in the treatment of Multirefractory Beh\u00e7et\u2019s disease","volume":"36","author":"Vitale","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.301","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.10.024"},{"issue":"3 Suppl 72","key":"2025090411013412000_23.5.386.302","first-page":"S73","article-title":"Refractory neuro-Beh\u00e7et treated by Tocilizumab: a case report","volume":"30","author":"Urbaniak","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2025090411013412000_23.5.386.303","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.08.004"},{"key":"2025090411013412000_23.5.386.304","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/1756-185X.12680","article-title":"Interleukin-1 blockade in neuro-Beh\u00e7et\u2019s disease: a case-based reflection","volume":"20","author":"Vitale","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2025090411013412000_23.5.386.305","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-015-3004-0","article-title":"Efficacy and safety profile of anti-Interleukin-1 treatment in Beh\u00e7et\u2019s disease: a multicenter retrospective study","volume":"35","author":"Emmi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2025090411013412000_23.5.386.306","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s00415-015-7897-y","article-title":"Rituximab is effective in severe treatment-resistant neurological Beh\u00e7et\u2019s syndrome","volume":"262","author":"Kidd","year":"2015","journal-title":"J Neurol"},{"key":"2025090411013412000_23.5.386.307","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jocn.2016.03.020","article-title":"Neuro-Beh\u00e7et's disease presenting with tumour-like lesions and responding to Rituximab","volume":"32","author":"Jade","year":"2016","journal-title":"J Clin Neurosci"},{"key":"2025090411013412000_23.5.386.308","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg424"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2023-003875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T18:09:36Z","timestamp":1757009376000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2023-003875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":308,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10,2]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/pn-2023-003875"],"URL":"https:\/\/doi.org\/10.1136\/pn-2023-003875","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}